- Home
- CLLS vs BCAL Comparison
CLLS vs BCAL Comparison
Compare CLLS & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLLS | BCAL |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.5M | 528.7M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLLS | BCAL |
|---|---|---|
| Price | $4.99 | $18.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $8.50 | ★ $20.00 |
| AVG Volume (30 Days) | 112.6K | ★ 230.8K |
| Earning Date | 11-07-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.92 |
| Revenue | $82,551,000.00 | ★ $187,714,000.00 |
| Revenue This Year | $32.58 | $73.26 |
| Revenue Next Year | $20.68 | $3.29 |
| P/E Ratio | ★ N/A | $9.83 |
| Revenue Growth | 129.04 | ★ 139.72 |
| 52 Week Low | $1.10 | $11.87 |
| 52 Week High | $5.48 | $20.47 |
Technical Indicators
Market Signals| Indicator | CLLS | BCAL |
|---|---|---|
| Relative Strength Index (RSI) | 57.74 | 40.30 |
| Support Level | $4.67 | $18.87 |
| Resistance Level | $5.03 | $19.21 |
| Average True Range (ATR) | 0.28 | 0.39 |
| MACD | -0.00 | -0.17 |
| Stochastic Oscillator | 67.51 | 2.86 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.